Hear hear. Company is good enough on its own merits. Just blocks up the genuinely good posts.
If the numbers look the same or better in the morning TILS might find itself in the FTSE 250? How exciting.
Not many moons and rockets here Lukey. Just tailings heavy in silver and gold as well as a large deposit of (as yet unreachable) copper. Welcome.
Depends entirely on circumstance
Depends really. Moving out of ISA and then paying charges and tax may have not been worth it
Goodby to AIM. It shan't be missed.
Read the previous RNS filed.
Either way $57m was plonked in at £2 a share. Make of that what you will
Perhaps AccuStem is the culmination of that personal journey? Here is a piece of an article written in 2015;
He lost his partner Tiziana three years ago to triple negative breast cancer - in which chemotherapy, radiotherapy or surgery is the only option - and has named the company after her.
Mr Cerrone believes the research is on a long path but in a "new frontier" and the next challenge in its development is the first phase of safety trials.
"In life we don't always have the fortune of being able to make a good business deal and do something good for humanitarian purposes," he said.
"This is a unique situation as it resonates to a personal tragedy I've had. To have a great project and help contribute to a niche of an illness that killed a loved one in my life is the ultimate satisfaction."
It is getting a tad "wacky races" in here.
Apologies on link. Thios should be the right one.
https://www.barrons.com/articles/regeneron-inks-deal-to-sell-covid-19-treatment-to-u-s-even-as-usage-lags-51610545649
The newest addition to our team is well linked with Regeneron. Haven't seen the article shared yet so I've linked it below. Perhaps I'm just seeing ghosts but Regeneron have a target to reach and probably many more doses to follow. All speculation of course.
https://www.barrons.com/articles/zscaler-stock-rallies-as-analysts-pound-the-table-after-meeting-with-management-51610490415
Probably the only way to prevent us from entering the Euro at the time (he was strongly against it and one of the few things he did right). If that is the case then good on him. If not then silly move
Very much agree Y-Alam. Life changing potential of Foralumab for so many people. The toxicity profile is great too. Excellent news all around
As expected leading up to the market listing we are entering a news rich period. I hope to see many more RNS as we move onto main market. The science speaks for itself.
I'm sure Regeneron have excellent production facilities and distribution lines.
Evening Setanta. Hope you're well and investment here is doing you proud. I believe a gravity separation plant on the GWMO wholly owned acreage would be affordable at far less than $2m. Perhaps you are forgetting that they do not need to process massive amounts quickly and therefore only need a modest setup which costs significantly less. A leaching plant would be more costly but both would have the benefit of being used commercially by other operators nearby (perhaps they'll even use the gravity plant). With regards to being put off by the road I'm fairly sure BH mentions that they could get an initial drilling rig up there using pickup trucks (to get some drilling going asap into the mine links and that large anomalous patch on the survey) but I'm sure there was mention of NEEDING to enlarge the road in the future. I wonder why?! All the best and of course all in my opinion.
Looks like they might be slightly behind the first to market on oral MABs. Would be interesting to see if Q-sphera could be used for large endocrine compounds. Something like oral insulin is of course the dream.
Thanks for that. For a pharma that's actually not too bad either. Their delivery technology is the most appealing thing to me. Trouble is you need a partner with it.
To be fair 20m MCAP isn't absurd. Does anyone know how much cash they currently have on hand and what they yearly cash use is?
Many thanks